Tympanostomy tube delivery systems
Customize your policy alerts
Sign up for AmeriHealth Caritas Policy CCP.1558 alerts
Get alerted when Policy CCP.1558 changes without checking for updates manually.
Monitor payer policy activity
Defines AmeriHealth Caritas coverage stance for fully automated and single-pass tympanostomy tube delivery systems (including Tula, Hummingbird, Solo+), and applies to providers submitting related services for members covered by AmeriHealth Caritas.
A new clinical policy was created that classifies fully automated and automated tympanostomy tube delivery systems as investigational/not medically necessary.
Coverage Determination
Not medically necessary — Automated and fully automated delivery systems
Coverage determination
Statement from Coverage policy
Fully automated and automated tympanostomy tube placement systems are designated investigational/not clinically proven and are therefore not medically necessary for coverage.
Automated tympanostomy tube delivery systems, including iontophoresis-assisted systems and the Tula® System, are specifically considered investigational and are not covered as medically necessary services.
Relevant Coding
| 0583T | Tympanostomy (requiring insertion of ventilating tube), using an automated tube delivery system, iontophoresis local anesthesia |
Provider Actions and Billing Guidance
0583T — investigational / no approval
Services described by CPT Category III code 0583T (tympanostomy requiring insertion of ventilating tube, using an automated tube delivery system, iontophoresis local anesthesia) are considered investigational and not medically necessary; prior authorization is not supported for these investigational services.
- Do not submit prior authorization requests expecting approval for CPT 0583T under medical necessity coverage.
No step therapy or limits identified
No step therapy requirements or other utilization limits were identified in this policy for tympanostomy tube delivery systems.
Document clinical indication and delivery method
Document that the patient meets accepted clinical indications for tympanostomy tube insertion (for example, recurrent acute otitis media or chronic otitis media with effusion) and record the specific delivery method used.
- Indication (e.g., recurrent acute otitis media or chronic otitis media with effusion).
- Delivery method used (e.g., fully automated system, single-pass device, manual insertion).
- Follow-up plan per guideline recommendations (ear examination within three months and routine periodic follow-up until tube extrusion).
Investigational service — claim denial risk
Claims for fully automated or automated tympanostomy tube placement systems (including automated tube delivery systems, iontophoresis-assisted systems, and the Tula System) are investigational/not clinically proven and therefore risk denial when submitted for medical necessity coverage.
- Expect denials for claims submitted with codes describing investigational automated delivery (e.g., CPT 0583T).
Background
Tympanostomy tube delivery systems are technologies intended to facilitate placement of ventilating tubes in office or lower-acuity settings as an alternative to operating room placement under general anesthesia. This policy's purpose is to define AmeriHealth Caritas' coverage stance for these delivery systems; because fully automated and automated platforms (for example, the Tula® System) are considered investigational, claims for those methods are not supported as medically necessary.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.